Myopathies are a heterogeneous group of disorders that affect the muscle channel, structure, or metabolism. This chapter will provide a diagnostic approach to a patient with suspected muscle disease based upon clinical history and examination. It will also provide a phenotypical approach to diagnosis based on the predominant pattern of weakness. Finally, laboratory testing that can be performed to confirm the suspected diagnosis of myopathy will be discussed.
INTRODUCTION
Myopathies are disorders in which a primary functional or structural impairment of skeletal muscle exists. Myopathies can be distinguished from other disorders of the motor unit, including motor neuron disorders, peripheral neuropathies, and neuromuscular junction diseases, by characteristic clinical and laboratory features. Therefore, the first goal in approaching a patient with a suspected muscle disease is to determine the correct site of the lesion. Once localized to the muscle, the next step is to identify whether the myopathy is due to a defect in the muscle channel, muscle structure, or a dysfunction in muscle metabolism. The second goal is to determine the cause of the myopathy. In general, myopathies can be classified into hereditary and acquired disorders (Table 1-1). The third goal is to determine whether a specific treatment is available and if not, to optimally manage the patient's symptoms to maximize his or her functional abilities and enhance quality of life.
CLINICAL EVALUATION
The most important element of evaluating a patient with a suspected myopathy is obtaining a thorough history. This should allow the physician to make a reasonable preliminary diagnosis that places the patient into one of the categories in Table 1-1. The findings on the physical examination, and in particular the distribution of muscle weakness, should provide additional information in determining the correct diagnosis. The results of the laboratory studies (blood tests, electromyogram [EMG] , muscle biopsy, molecular genetic studies) then play a confirmatory diagnostic role.
The first step in approaching a patient is to ask six key questions based on the patient's symptoms and signs.
(1) Which negative and/or positive symptoms and signs does the patient demonstrate?
Symptoms and signs of muscle disease (Table 1 -2) can be divided into negative complaints such as weakness, exercise intolerance, fatigue, and muscle atrophy, and positive complaints such as myalgias, cramps, contractures, myoglobinuria, and muscle stiffness (Barohn, 2004) .
Weakness is by far the most common negative symptom reported by a patient with muscle disease. If the weakness involves the lower extremities, patients will complain of difficulty climbing stairs, arising from a low chair or toilet, or getting up from a squatted position. When the upper extremities are involved, patients notice trouble lifting objects over their head and brushing their hair. These symptoms in the arms and legs indicate proximal muscle weakness, which is probably the most common type of weakness in a myopathic disorder (see below). Less commonly, patients with myopathies can complain of distal weakness manifested as difficulty opening jars, inability to turn a key in the ignition, or tripping due to footdrop. Some myopathies may also result in cranial muscle weakness, resulting in complaints of dysarthria, dysphagia, or ptosis.
Fatigue is a much less useful negative symptom, as it is nonspecific and may reflect a patient's cardiopulmonary status, level of conditioning, overall health, sleeping habits, or emotional state. Many patients who complain of diffuse global weakness or fatigue do not have a muscle disorder, particularly if the neurological examination is normal. On the other hand, abnormal fatigability after exercise can result from certain metabolic and mitochondrial myopathies, and it is important to define the duration and intensity of exercise that provokes the fatigue.
Positive symptoms associated with myopathies may include myalgias, cramps, contractures, myotonia, or myoglobinuria. Myalgia, like fatigue, is another nonspecific symptom of some myopathies (Table 1-3) . Myalgias may be episodic (metabolic myopathies) or nearly constant (inflammatory muscle disorders). However, pain is usually not common in most muscle diseases and is more likely to be due to orthopedic or rheumatological disorders (Kincaid, 1997). It is rare for a muscle disease to be responsible for vague aches and muscle discomfort in the presence of a normal neuromuscular examination and laboratory studies. A specific type of muscle pain is the involuntary muscle cramp. Cramps may last from seconds to minutes and are usually localized to a particular muscle region. They are typically benign, occurring frequently in normal individuals, and are seldom a feature of a primary myopathy. Cramps are characterized by rapidly firing motor unit discharges, which can be demonstrated on needle EMG. Cramps can occur with dehydration, hyponatremia, azotemia, and myxedema and in disorders of the nerve or motor neuron (especially amyotrophic lateral sclerosis).
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Muscle contractures are uncommon but can superficially resemble a cramp. They are typically provoked by exercise in patients with glycolytic enzyme defects. Contractures differ from cramps in that they usually last longer and are electrically silent with needle EMG. Muscle disorders that are associated with contractures are listed in Table 1-4. Myotonia is the phenomenon of impaired relaxation of muscle after forceful voluntary contraction and most commonly involves the hands and eyelids. Myotonia is due to repetitive depolarization of the muscle membrane.
Patients may complain of muscle stiffness or tightness resulting in difficulty releasing their handgrip after a handshake, unscrewing a bottle top, or Myoglobinuria is a relatively uncommon manifestation of muscle disease and is caused by the excessive release of myoglobin from muscle during periods of rapid muscle destruction (rhabdomyolysis). Severe myoglobinuria can result in renal failure due to acute tubular necrosis. If patients complain of exercise-induced weakness and myalgias, they should be asked if their urine has ever turned cola-colored or red during or after these episodes.
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Recurrent myoglobinuria is usually due to an underlying metabolic myopathy (Table 1-6), whereas isolated episodes, particularly occurring after unaccustomed strenuous exercise, are frequently idiopathic.
(2) What is the temporal evolution?
It is obviously important to determine the onset, duration, and evolution of the patient's symptoms and signs of muscle disease. Did the weakness (or other symptoms) first manifest at birth, or was the onset in the first, second, third, or a later decade (Table 1-7)? It is also imperative to determine the evolution and duration of the disease. Myopathies can present with either constant weakness (muscular dystrophies, inflammatory myopathies) or episodic periods of weakness with normal strength interictally (periodic paralysis, metabolic myopathies due to certain glycolytic pathway disorders). The episodic disorders have acute weakness that can return to normal strength within hours or days. The tempo of the disorders with constant weakness can vary among: (1) acute or subacute progression in some inflammatory myopathies (dermatomyositis and polymyositis); (2) chronic slow progression over years (most muscular dystrophies); or (3) nonprogressive weakness with little change over decades (congenital myopathies). Finally, both constant and episodic myopathic disorders can have symptoms that may be monophasic or relapsing. For example, polymyositis can occasionally have an acute monophasic course with complete resolution of strength within weeks or months. Patients with periodic paralysis or metabolic myopathies can have recurrent attacks of weakness over many years, whereas a patient with acute rhabdomyolysis due to cocaine may have a single episode. (3) Is there a family history of a myopathic disorder?
Since many myopathies are inherited, obtaining a thorough family history is clearly of great importance in making a correct diagnosis. A detailed family tree should be completed to look for evidence of autosomal dominant, autosomal recessive, and X-linked patterns of transmission. Questions regarding family members' use of canes or wheelchairs, skeletal deformities, or functional limitations are usually more informative than questions such as, ''Does any member of your family have a muscle disease?'' Identifying a particular hereditary pattern not only may help in correctly diagnosing the specific myopathy (Table 1-8) but is also of tremendous importance in providing appropriate genetic counseling. (4) Are there precipitating factors that trigger episodic weakness or myotonia?
A history of precipitating factors that might trigger or exacerbate symptoms of weakness or myotonia should be explored. It is important to ask the patient if there is any history of either illegal drug or prescription medication use that might produce a myopathy. A history of weakness, pain, and/or myoglobinuria that is provoked by exercise might suggest the possibility of a glycolytic pathway defect. Episodes of weakness that occur in association with a fever would be supportive of a diagnosis of carnitine palmityl transferase deficiency. Periodic paralysis is characteristically provoked by exercise or ingestion of a carbohydrate meal followed by a period of rest. Patients with paramyotonia congenita frequently report that cold exposure may precipitate their symptoms of muscle stiffness.
(5) Are associated systemic symptoms or signs present? Involvement of organs or tissues other than muscle may also provide helpful clues in making the appropriate diagnosis. Cardiac disease (Table 1-9) may be associated with myotonic dystrophy, Duchenne or Becker muscular dystrophies, LGMD1B (laminopathy), LGMD2I (fukutin-related protein), LGMD2C-2F (sarcoglycanopathies), LGMD2G (telethoninopathy), Emery-Dreifuss muscular dystrophy, and Andersen syndrome.
Respiratory failure may be the presenting symptom of myotonic dystrophy, centronuclear myopathy, nemaline myopathy, or acid maltase deficiency (Table 1-10). Eventually, most myopathies will affect respiratory muscle strength, highlighting the need for consistent monitoring of pulmonary function studies throughout the disease course. Once symptoms of hypoventilation are evident, supportive care with noninvasive positive pressure ventilation and assistive devices for clearance of upper airway secretions should be used.
Hepatomegaly may be seen in myopathies associated with deficiencies in acid maltase, debranching enzyme, and carnitine. The presence of cataracts, frontal balding, and mental retardation strongly suggests the diagnosis of myotonic dystrophy. Dysmorphic features may be associated with the congenital myopathies. The presence of a rash is extremely helpful in confirming the diagnosis of dermatomyositis. Musculoskeletal contractures can occur in many myopathies of long-standing duration. However, contractures developing early in the course of the disease, especially at the elbows, can be a clue to Emery-Dreifuss dystrophy, LGMD1B (laminopathy), and Bethlem myopathy. Evidence of diffuse systemic disease can indicate amyloidosis, sarcoidosis, endocrinopathy, collagen-vascular disease, infectious disease, or a mitochondrial disorder.
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(6) What is the distribution of weakness?
To determine the distribution of muscle weakness, it is important to know which muscles to test and how to grade their power. Muscle strength can be tested by manual testing and from observation of functional activity (Table 1-11) (Brooke, 1986) . Functional testing is particularly informative in young children who usually cannot cooperate with formal manual muscle testing and in adults with ''give-way'' weakness who present with complaints of muscle pain.
In performing manual muscle testing of the upper extremities, it is necessary to assess shoulder abduction and external and internal rotation; elbow flexion and extension; wrist flexion and extension; and finger and thumb extension, flexion, and abduction. Muscle groups that should be tested in the lower extremities include hip flexion, extension, and abduction; knee flexion and extension; ankle dorsiflexion, plantar flexion, inversion, and eversion; and toe extension and flexion. All muscle groups should be tested bilaterally and preferably against gravity. Neck flexors should be assessed in the supine position and neck extensors in the prone position. Knee extension and hip flexion should be tested in the seated position, knee flexion should be tested in the prone position, and hip abduction should be tested in the lateral decubitus position. If testing against gravity is not done, the presence of significant muscle weakness can escape recognition. Assessment of muscle strength is usually based on the expanded Medical Research Council (MRC) of Great Britain grading scale of 0 to 5 (Table 1-12) (Medical Research Council, 2000) . Finally, cranial nerve muscles such as the orbicularis oculi and oris, extraocular muscles, tongue, and palate should be examined. These may be best tested by observation of the patient performing functional activities such as whistling, sucking from a straw, and smiling.
In addition to manual muscle testing and functional testing, muscles should be inspected for evidence of atrophy or hypertrophy. Atrophy of proximal limb muscles is common in most chronic myopathies. However, certain myopathies may demonstrate atrophy in specific groups that correspond to severe weakness in those muscles and provide additional diagnostic clues. For example, atrophy of the periscapular muscles associated with scapular winging is characteristic of facioscapulohumeral dystrophy. Scapular winging is also seen in patients with LGMD1B (laminopathy), LGMD2A (calpainopathy), and LGMD2C-2F (sarcoglycanopathies). Selective atrophy of the quadriceps muscles and forearm flexor muscles is highly suggestive of inclusion body myositis. Distal myopathies may have profound atrophy of the anterior or posterior lower extremity compartments. On the other hand, muscles can show evidence of hypertrophy in some myotonic conditions such as myotonia congenita. Muscle hypertrophy is also a characteristic of disorders including amyloidosis, sarcoidosis, and hypothyroid myopathy. In Duchenne and Becker dystrophy, the calf muscles demonstrate ''pseudohypertrophy'' due to replacement with connective tissue and fat. Calf muscle hypertrophy is also characteristically seen in LGMD2C-2F (sarcoglycanopathies) and LGMD2I (fukutin-related protein). In LGMD2G (telethoninopathy), 50% of the patients will show calf hypertrophy and 50% will demonstrate calf atrophy. Focal muscle enlargement can also be due to a neoplastic or inflammatory process, ectopic ossification, tendon rupture, or partial denervation.
PATTERN-RECOGNITION APPROACH TO MYOPATHIC DISORDERS
After answering the six key questions obtained from the history and neurological examination outlined above, one can attempt to classify a myopathic disorder into one of six distinctive patterns of muscle weakness, each with a limited differential diagnosis. The final diagnosis can then be confirmed based on information from a selective number of laboratory studies. 
Pattern 4: Distal Arm/Proximal Leg Weakness
This pattern is associated with distal arm weakness involving the distal forearm muscles (wrist and finger flexors) and proximal leg weakness involving the knee extensors (quadriceps). The facial muscles are usually spared. Involvement of other muscles is extremely variable. In addition, the weakness is often asymmetrical between the two sides, which is uncommon in most myopathies. This pattern is essentially pathognomonic for inclusion body myositis (IBM). This pattern may also represent an uncommon presentation of myotonic dystropy; however, unlike IBM, muscle weakness is usually symmetrical (Case 1-1).
Pattern 5: Ptosis With or Without Ophthalmoplegia
Myopathies presenting with predominant involvement of ocular and/or pharyngeal muscles represent a relatively limited group of disorders. (Table 1-14) .
The eye involvement principally results in ptosis and ophthalmoplegia, which usually, although not always, occurs without symptoms of diplopia. Facial weakness is not uncommon, and extremity weakness is extremely variable, depending on the diagnosis. The combination of ptosis, ophthalmoplegia without diplopia, and dysphagia should suggest the diagnosis of oculopharyngeal dystrophy, especially if the onset is in middle age or later (Case 1-2). Ptosis and ophthalmoplegia without prominent pharyngeal involvement is a hallmark of many of the mitochondrial myopathies. Ptosis and facial weakness without ophthalmoplegia is a common feature of myotonic dystrophy.
Pattern 6: Prominent Neck Extensor Weakness
This pattern is characterized by severe weakness of the neck extensor muscles. The term ''dropped head syndrome'' has been used in this situation ( 
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Case 1-1
A 51-year-old man without significant past medical history is referred for evaluation of slowly progressive muscle weakness for the past 7 years. His symptoms initially began with difficulty walking down stairs because his left knee would ''give out.'' He currently has difficulty arising from a chair and grasping objects with his right hand. When a neurologist initially evaluated him 2 years ago, the workup included a creatine kinase (CK) level of 500 IU/L and a left quadriceps muscle biopsy, which was consistent with ''polymyositis.'' The patient has been treated with a variety of immunosuppressive medications, including prednisone, methotrexate, and azathioprine, with continued progression of his weakness. Current examination reveals intact cranial nerves, sensation, and muscle stretch reflexes. Motor examination in the right upper extremity shows MRC grade 5 shoulder abduction, grade 5 elbow flexion/extension, grade 4 wrist flexion, grade 5 wrist extension, and grade 3À finger flexion. Strength in the left upper extremity is normal except for grade 4+ finger flexion. In the left lower extremity, the patient exhibits grade 4+ hip flexion, grade 3+ knee extension, and grade 4+ ankle dorsiflexion. In the right lower extremity, strength is normal except for grade 4+ knee extension. Comment. The chronic onset, asymmetrical distribution of weakness, and selective involvement of wrist/finger flexion and knee extension are most consistent with a diagnosis of IBM. In many cases, initial muscle biopsy fails to identify vacuoles, and patients are inappropriately treated with immunosuppressant medications for presumptive polymyositis. In patients with a phenotype consistent with IBM, particularly if they are ''refractory'' to treatment, a repeat biopsy may be necessary to clarify the diagnosis. 
LABORATORY APPROACH IN THE EVALUATION OF A SUSPECTED MYOPATHY
Creatine Kinase CK is the single most useful laboratory study for the evaluation of patients with a suspected myopathy. The CK is elevated in the majority of patients with muscle disease but may be normal in slowly progressive myopathies. The degree of CK elevation can also be helpful in distinguishing different forms of muscular dystrophy. For example, in Duchenne dystrophy, the CK level is invariably at least 10 times (and often up to 100 times) normal, whereas in most other myopathies the CK elevation is lower. The other exceptions are LGMD1C (caveolinopathy), LGMD2A (calpainopathy), and LGMD2B (dysferlinopathy), where CK may also be markedly elevated. The CK level may not be elevated in some myopathies or may even be lowered by a number of factors, including profound muscle wasting, corticosteroid administration, collagen diseases, alcoholism, or hyperthyroidism.
It is also important to remember that an elevation of serum CK does not necessarily imply a primary myopathic disorder (Table 1-16 ). Many times the CK level will rise modestly (usually to less than 10 times normal) in motor neuron disease, and, uncommonly, CK elevations may be seen in GuillainBarré syndrome or chronic inflammatory demyelinating neuropathy. Endocrine disorders such as hypothyroidism
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Case 1-2
A 62-year-old white woman with a family history of ''myasthenia gravis'' presents for evaluation of an 8-year history of progressive dysphagia and weakness. She specifically denies any symptoms of diplopia and states that her symptoms do not fluctuate during the day or when she becomes fatigued. She has noted no improvement with a course of prednisone 60 mg/d and pyridostigmine 60 mg 4 times daily. Cranial nerve examination is remarkable for bilateral ptosis, incomplete abduction/adduction of both eyes, mild orbicularis oris weakness, and moderate tongue weakness. Motor examination reveals MRC grade 4 neck flexion, grade 4 shoulder abduction, grade 4+ elbow flexion, grade 5 finger extension, grade 4 hip flexion, grade 5 knee extension, and grade 5 ankle dorsiflexion and plantarflexion. Sensory, cerebellar, and reflex examinations are normal. Workup by a referring physician was remarkable for a CK level of 350 IU/L and a negative acetylcholine receptor antibody.
Comment. The patient's distribution of weakness (ptosis, ophthalmoparesis, dysphagia, and proximal weakness), age of onset, and positive family history would be most suggestive of a diagnosis of oculopharyngeal muscular dystrophy. The absence of symptoms of diplopia and muscle fatigability and the patient's slowly progressive course strongly argue against a diagnosis of a neuromuscular junction disorder such as myasthenia gravis. Race and gender can also affect serum CK (Wong et al, 1983) . CK levels are frequently above the normal range in some African American individuals and in patients with enlarged muscles. Occasionally, benign elevations of CK appear on a hereditary basis. It is extremely unusual for a slightly elevated CK level (threefold or less) to be associated with an underlying myopathy in the absence of objective muscle weakness or pain.
Serum tests for other muscle enzymes such as aldolase are significantly less helpful than the determination of the CK. Enzymes such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) may be slightly elevated in myopathies. Since AST, ALT, and LDH are often measured in screening chemistry panels, their elevation should prompt CK measurement to determine whether the source is muscle or liver. If a patient with an inflammatory myopathy is treated with an immunosuppressive agent that may cause hepatoxicity, the liver-specific enzyme gamma glutamic transferase (GGT) should be followed. In general, CK isoenzymes are not helpful in evaluating myopathies. CKfraction muscle (MM) elevations are typical of muscle disease, but CKmyocardial band (MB) is also elevated in myopathies and does not indicate that cardiac disease is present.
Electrophysiological Studies
Electrodiagnostic studies, consisting of both nerve conduction studies and EMG, should be part of the routine evaluation of a patient with a suspected myopathy (Preston and Shapiro, 2005) . These studies are helpful in confirming that the muscle is, indeed, the correct site of the lesion and that weakness is not the result of an underlying motor neuron disease, neuropathy, or neuromuscular junction disorder. Nerve conduction studies are typically normal in patients with myopathy. Needle EMG examination showing evidence of briefduration, small-amplitude motor units with increased recruitment can be extremely helpful in confirming the presence of a myopathy. Needle EMG can also provide a clue as to which muscles have had recent or ongoing muscle injury and can be a guide as to which muscle to biopsy. It is important to realize, however, that the EMG can be normal in a patient with myopathy, and the results of electrodiagnostic studies need to be evaluated in the context of the patient's history, neurological examination, and other laboratory studies.
The Muscle Biopsy
If the clinical features and/or electrodiagnostic features suggest the possibility of a myopathy, a muscle biopsy may be an appropriate test to confirm the diagnosis (Dubowitz, 1985) . However, many forms of hereditary muscle disorders can now be diagnosed with molecular genetic testing, thereby eliminating the need for a muscle biopsy in every patient. A muscle specimen can be obtained through either an open or closed (needle or punch) biopsy procedure. The advantage of a needle or punch biopsy is that it is minimally invasive, cosmetically more appealing, and multiple specimens can be obtained. The disadvantage of the closed biopsy procedure is that not all laboratories have the expertise to adequately process the muscle tissue acquired with this approach for all the necessary studies. In addition, a needle biopsy may miss a focal area of inflammation.
Selection of the appropriate muscle to biopsy is critical. Muscles that are severely weak (MRC grade 3 or less) should not be biopsied, since the results are likely to show only evidence of end stage muscle disease. In addition, muscles that have recently been studied by needle EMG should be avoided because of the possibility of artifacts created by needle insertion. Biopsies should generally be taken from muscles that demonstrate MRC grade 4 strength. For practical purposes, in the upper extremities, the muscle of choice is the biceps; in the lower extremities, the best choice is the vastus lateralis. The gastrocnemius should be avoided, since its tendon insertion extends throughout the muscle and inadvertent sampling of a myotendinous junction may cause difficulty with interpretation. Occasionally, an imaging procedure such as muscle ultrasound, computed tomography, or magnetic resonance imaging can be used to guide selection of the appropriate muscle to biopsy.
Biopsy specimens can be analyzed by light microscopy, electron microscopy, biochemical studies, and immune staining ( " SUSPECTED MYOPATHY muscle tissue specimens are sufficient to make a pathological diagnosis. Typical myopathic abnormalities include central nuclei, both small and large hypertrophic round fibers, split fibers, and degenerating and regenerating fibers. Inflammatory myopathies are characterized by the presence of mononuclear inflammatory cells in the endomysial and perimysial connective tissue between fibers and occasionally around blood vessels. In addition, in dermatomyositis, perifascicular atrophy, characterized by atrophy of fibers located on the periphery of a muscle fascicle, is a common finding. Chronic myopathies frequently show evidence of increased connective tissue and fat.
For general histology, the hematoxylin and eosin (H&E) and modified Gomori trichrome are most useful. The latter is particularly helpful in identifying ragged red fibers, which might suggest a mitochondrial disorder.
In addition to these standard stains, other histochemical reactions can be used to gain additional information (Table 1-19) . The myosin adenosine triphosphatase stains (alkaline pH 9.4 and acidic pH 4.3 and 4.6) allow a thorough evaluation of histochemistry fiber types. Type 1 fibers (slow-twitch, fatigue-resistant, oxidative metabolism) stain lightly at alkaline and darkly at acidic pH levels. Type 2 fibers (fasttwitch, fatigue-prone, glycolytic metabolism) stain darkly at alkaline and lightly at acidic pH levels. Normally, a random distribution of the two fiber types occurs, and generally twice as many type 2 as type 1 fibers are identified. In a number of myopathies, a nonspecific type 1 fiber predominance occurs. Electron microscopy evaluates the ultrastructural components of muscle fibers and is not required in the majority of myopathies to make a pathologic diagnosis. Electron microscopy is important, however, in the diagnosis of some congenital myopathies and mitochondrial disorders. Findings detected only by electron microscopy are seldom of clinical importance.
The muscle tissue can also be processed for biochemical analysis to determine a specific enzyme defect in the evaluation of a possible metabolic or mitochondrial myopathy. In addition, Western blot determinations from muscle tissue can be performed for certain muscle proteins. This type of analysis is usually limited to dystrophin assays when immune stains and molecular genetic studies are inconclusive in establishing a diagnosis of either Duchenne or Becker dystrophy.
Molecular Genetic Studies
The specific molecular genetic defect is now known for a large number of hereditary myopathies, and mutations can be identified by peripheral blood DNA analysis. Molecular genetic studies that are commercially available are included in Table 1 
